From: Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma
Patients | Site | Size (cm) | Lung | Pleura | Contralateral lung involvement | Lymphadenopathy | Extrathoracic sites | SUV |
---|---|---|---|---|---|---|---|---|
1 | RUL, Central | 5.5 × 4.1 | Post-obstructive atelectasis | Large effusion, Pleural nodules | Small right-sided effusion | Hilar(L), Mediastinal(B) | Bone | 10.6 |
2 | RUL, Central | 5.4 × 3.7 | Post-obstructive atelectasis | Small effusion | None | Supraclavicular(R), Hilar(R), Mediastinal(R) | Bone Adrenal gland | 18.6 |
3 | RLL, Central | 4.7 × 4.7 × 4.7 | Post-obstructive atelectasis | Medium pleural effusion | Small left-sided effusion | Supraclavicular(B), Hilar(B), Axillary(B), Mediastinal(B) | Bone | NA |
4 | RLL, Central | 10 × 6.4 × 12.7 | Intrapulmonary metastasis, Pulmonary vascular invasion | Large effusion, Pleural nodules | None | Hilar(R), Mediastinal(R) | Pericardium, back(R) | NA |
5 | LLL, RUL, Peripheral | 2.8 × 2.0 5.3 × 4.8 | None | None | Lung | Supraclavicular(R), Hilar(L), Mediastinal(L) | None | 13.6 18.4 |
6 | OT | 4 cm long | None | None | None | Posterior tracheal, Hilar(R),Mediastinal(B) | Oesophagus | NA |
7 | LT | 3.0 × 3.1 × 3.1 | None | None | None | Mediastinal(B) | None | NA |